|
1.
|
Thorvaldsen P, Kuulasmaa K, Rajakangas AM,
et al: Stroke trends in the WHO MONICA project. Stroke. 28:500–506.
1997. View Article : Google Scholar
|
|
2.
|
Delcker A, Diener HC and Wilhelm H:
Influence of vascular risk factors for atherosclerotic carotid
artery plaque progression. Stroke. 26:2016–2022. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Remaley AT, Stonik JA, Demosky SJ, et al:
Apolipoprotein specificity for lipid efflux by the human ABCAI
transporter. Biochem Biophys Res Commun. 280:818–823. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Wang N, Silver DL, Thiele C, et al:
ATP-binding cassette transporter A1 (ABCA1) functions as a
cholesterol efflux regulatory protein. J Biol Chem.
276:23742–23747. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Burris TP, Eacho PI and Cao G: Genetic
disorders associated with ATP binding cassette cholesterol
transporters. Mol Genet Metab. 77:13–20. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Oram JF, Lawn RM, Garvin MR, et al: ABCA1
is the cAMP-inducible apolipoprotein receptor that mediates
cholesterol secretion from macrophages. J Biol Chem.
275:34508–34511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Aiello RJ, Brees D, Bourassa PA, et al:
Increased atherosclerosis in hyperlipidemic mice with inactivation
of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol. 22:630–637.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
van Dam MJ, de Groot E, Clee SM, et al:
Association between increased arterial-wall thickness and
impairment in ABCA1-driven cholesterol efflux: an observational
study. Lancet. 359:37–42. 2002.PubMed/NCBI
|
|
9.
|
Stary HC, Chandler AB, Dinsmore RE, et al:
A definition of advanced types of atherosclerotic lesions and a
histological classification of atherosclerosis. A report from the
Committee on Vascular Lesions of the Council on Arteriosclerosis,
American Heart Association. Arterioscler Thromb Vasc Biol.
15:1512–1531. 1995. View Article : Google Scholar
|
|
10.
|
Bodzioch M, Orso E, Klucken J, et al: The
gene encoding ATP-binding cassette transporter 1 is mutated in
Tangier disease. Nat Genet. 22:347–351. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Wellington CL, Walker EK, Suarez A, et al:
ABCA1 mRNA and protein distribution patterns predict multiple
different roles and levels of regulation. Lab Invest. 82:273–283.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Albrecht C, Soumian S, Amey JS, et al:
ABCA1 expression in carotid atherosclerotic plaques. Stroke.
35:2801–2806. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Virmani R, Kolodgie FD, Burke AP, et al:
Lessons from sudden coronary death: a comprehensive morphological
classification scheme for atherosclerotic lesions. Arterioscler
Thromb Vasc Biol. 20:1262–1275. 2000. View Article : Google Scholar
|
|
14.
|
Lawn RM, Wade DP, Couse TL, et al:
Localization of human ATP-binding cassette transporter 1 (ABC1) in
normal and atherosclerotic tissues. Arterioscler Thromb Vasc Biol.
21:378–385. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Soumian S, Albrecht C, Davies AH, et al:
ABCA1 and atherosclerosis. Vasc Med. 10:109–119. 2005. View Article : Google Scholar
|
|
16.
|
Tabas I: Free cholesterol-induced
cytotoxicity a possible contributing factor to macrophage foam cell
necrosis in advanced atherosclerotic lesions. Trends Cardiovasc
Med. 7:256–263. 1997.PubMed/NCBI
|
|
17.
|
Langmann T, Klucken J, Reil M, et al:
Molecular cloning of the human ATP-binding cassette transporter 1
(hABC1): evidence for sterol-dependent regulation in macrophages.
Biochem Biophys Res Commun. 257:29–33. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Liao H, Langmann T, Schmitz G, et al:
Native LDL upregulation of ATP-binding cassette transporter-1 in
human vascular endothelial cells. Arterioscler Thromb Vasc Biol.
22:127–132. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Costet P, Luo Y, Wang N, et al:
Sterol-dependent transactivation of the ABC1 promoter by the liver
X receptor/retinoid X receptor. J Biol Chem. 275:28240–28245.
2000.PubMed/NCBI
|
|
20.
|
Fu X, Menke JG, Chen Y, et al:
27-Hydroxycholesterol is an endogenous ligand for liver X receptor
in cholesterol-loaded cells. J Biol Chem. 276:38378–38387. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Wagner BL, Valledor AF, Shao G, et al:
Promoter-specific roles for liver X receptor/corepressor complexes
in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell
Biol. 23:5780–5789. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Uehara Y, Engel T, Li Z, et al:
Polyunsaturated fatty acids and acetoacetate downregulate the
expression of the ATP-binding cassette transporter A1. Diabetes.
51:2922–2928. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Schwartz K, Lawn RM and Wade DP: ABC1 gene
expression and ApoA-I-mediated cholesterol efflux are regulated by
LXR. Biochem Biophys Res Commun. 274:794–802. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Wang N, Chen W, Linsel-Nitschke P, et al:
A PEST sequence in ABCA1 regulates degradation by calpain protease
and stabilization of ABCA1 by apoA-I. J Clin Invest. 111:99–107.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Cui H, Okuhira K, Ohoka N, et al:
Tributyltin chloride induces ABCA1 expression and apolipoprotein
A-I-mediated cellular cholesterol efflux by activating
LXRalpha/RXR. Biochem Pharmacol. 81:819–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Laffitte BA, Joseph SB, Walczak R, et al:
Autoregulation of the human liver X receptor alpha promoter. Mol
Cell Biol. 21:7558–7568. 2001. View Article : Google Scholar : PubMed/NCBI
|
